Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€4.10
04.10.22
-
04.10.23
14.15%
25.10.22

Probably not worthwhile Investment
buy
Carmat

Start price
Target price
Perf. (%)
€14.84
30.03.22
€18.00
30.03.23
-17.45%
22.10.22

Could be worthwhile Investment >10% per year
buy
Biosynex

Start price
Target price
Perf. (%)
€15.66
20.10.21
€17.00
20.10.22
-21.52%
21.10.22

Could be worthwhile Investment >10% per year
buy
Korian S.A.

Start price
Target price
Perf. (%)
€28.30
17.10.21
€30.00
17.10.22
-62.44%
18.10.22

Could be worthwhile Investment >10% per year
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€1.97
10.10.22
€0.000
10.10.23
-6.09%
16.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.26
03.10.22
€3.00
03.10.23
22.12%
06.10.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-3.77%
01.10.22

Risky Investment
Koninklijke Philips Electronics

Start price
Target price
Perf. (%)
€15.79
27.09.22
€12.00
27.09.23
-0.06%
01.10.22

Henry Schein Inc.

Start price
Target price
Perf. (%)
€67.50
29.09.21
€65.00
29.09.22
0.87%
30.09.22

Could be worthwhile Investment >10% per year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€101.00
28.09.21
€105.00
28.09.22
-87.18%
29.09.22

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€20.00
12.09.21
€23.00
12.09.22
-1.50%
13.09.22

Could be worthwhile Investment >10% per year
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€36.50
22.08.22
€66.00
22.08.23
-8.22%
03.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€25.58
22.08.22
€44.00
22.08.23
-5.00%
03.09.22

Could be very worthwhile Investment >20% year
Capable Management
Good culture
Innovative
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€200.00
06.09.21
€300.00
31.12.23
49.10%
01.09.22

Could be very worthwhile Investment >20% year
buy
Molina Healthcare

Start price
Target price
Perf. (%)
€247.40
20.10.21
€280.00
31.12.23
39.05%
01.09.22

Could be very worthwhile Investment >20% year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€390.10
20.10.21
€460.00
31.12.23
25.56%
01.09.22

Could be very worthwhile Investment >20% year
buy
Agfa Gevaert N.V.

Start price
Target price
Perf. (%)
€4.44
26.08.21
€5.50
26.08.22
-25.11%
27.08.22

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.72
07.08.22
-
07.08.23
-13.98%
26.08.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€100.15
26.08.21
-
26.08.22
-2.84%
26.08.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€98.65
04.01.22
-
04.01.23
-56.84%
25.08.22

buy
Stratec SE

Start price
Target price
Perf. (%)
€132.00
23.12.21
-
23.12.22
-32.73%
25.08.22